Skip to main content
Erschienen in: Heart Failure Reviews 6/2019

04.07.2019 | Cardiomyopathy

Cardiogenic shock in cancer

verfasst von: Kalliopi Keramida, John T. Parissis, Ovidiu Chioncel, Dimitrios Farmakis

Erschienen in: Heart Failure Reviews | Ausgabe 6/2019

Einloggen, um Zugang zu erhalten

Abstract

Cardiogenic shock (CS) is increasingly recognized in patients with malignancies, while cancer is independently associated with worse prognosis in CS. A number of conditions may lead to CS in cancer, including acute coronary syndromes, cardiomyopathy, takotsubo syndrome, myocarditis, pulmonary embolism, tamponade, and cardiac herniation. In these conditions, CS may be related to cancer itself or to cancer therapy, including surgery, chemotherapy, or radiotherapy. Given the significantly improved overall survival of patients with malignancies, the early recognition and proper management of CS in cancer become increasingly important. In the present paper, we review the available evidence on CS in patients with malignancies and highlight issues related to its management.
Literatur
1.
Zurück zum Zitat Tubaro M, Vranckx P, Price S, Vrints C, European Society of C. The ESC textbook of intensive and acute cardiovascular care. 2016 Tubaro M, Vranckx P, Price S, Vrints C, European Society of C. The ESC textbook of intensive and acute cardiovascular care. 2016
2.
Zurück zum Zitat Chioncel O, Mebazaa A, Harjola VP, Coats AJ, Piepoli MF, Crespo-Leiro MG, Laroche C, Seferovic PM, Anker SD, Ferrari R, Ruschitzka F, Lopez-Fernandez S, Miani D, Filippatos G, Maggioni AP, on behalf of the ESC Heart Failure Long-Term Registry Investigators (2017) Clinical phenotypes and outcome of patients hospitalized for acute heart failure: the ESC Heart Failure Long-Term Registry. Eur J Heart Fail 19(10):1242–1254PubMedCrossRef Chioncel O, Mebazaa A, Harjola VP, Coats AJ, Piepoli MF, Crespo-Leiro MG, Laroche C, Seferovic PM, Anker SD, Ferrari R, Ruschitzka F, Lopez-Fernandez S, Miani D, Filippatos G, Maggioni AP, on behalf of the ESC Heart Failure Long-Term Registry Investigators (2017) Clinical phenotypes and outcome of patients hospitalized for acute heart failure: the ESC Heart Failure Long-Term Registry. Eur J Heart Fail 19(10):1242–1254PubMedCrossRef
3.
Zurück zum Zitat Puymirat E, Fagon JY, Aegerter P et al (2017) Cardiogenic shock in intensive care units: evolution of prevalence, patient profile, management and outcomes, 1997–2012. Eur J Heart Failure 19(2):192–200CrossRef Puymirat E, Fagon JY, Aegerter P et al (2017) Cardiogenic shock in intensive care units: evolution of prevalence, patient profile, management and outcomes, 1997–2012. Eur J Heart Failure 19(2):192–200CrossRef
4.
Zurück zum Zitat Shaefi S, O’Gara B, Kociol RD, Joynt K, Mueller A, Nizamuddin J, Mahmood E, Talmor D, Shahul S (2015) Effect of cardiogenic shock hospital volume on mortality in patients with cardiogenic shock. J Am Heart Assoc 4(1):e001462PubMedPubMedCentralCrossRef Shaefi S, O’Gara B, Kociol RD, Joynt K, Mueller A, Nizamuddin J, Mahmood E, Talmor D, Shahul S (2015) Effect of cardiogenic shock hospital volume on mortality in patients with cardiogenic shock. J Am Heart Assoc 4(1):e001462PubMedPubMedCentralCrossRef
5.
Zurück zum Zitat Rodriguez M, Sabharwal B, Wei X, Krittanawong C, Verheyen E, Herzog E. The effect of cancer on outcomes on acute heart failure exacerbations: a 5-year nationwide analysis. 2018;71(11 Supplement):A693 Rodriguez M, Sabharwal B, Wei X, Krittanawong C, Verheyen E, Herzog E. The effect of cancer on outcomes on acute heart failure exacerbations: a 5-year nationwide analysis. 2018;71(11 Supplement):A693
6.
Zurück zum Zitat Iliescu CA, Grines CL, Herrmann J et al (2016) SCAI expert consensus statement: evaluation, management, and special considerations of cardio-oncology patients in the cardiac catheterization laboratory (endorsed by the cardiological society of India, and sociedad Latino Americana de Cardiologia intervencionista). Catheter Cardiovasc Interv 87(5):E202–E223PubMedCrossRef Iliescu CA, Grines CL, Herrmann J et al (2016) SCAI expert consensus statement: evaluation, management, and special considerations of cardio-oncology patients in the cardiac catheterization laboratory (endorsed by the cardiological society of India, and sociedad Latino Americana de Cardiologia intervencionista). Catheter Cardiovasc Interv 87(5):E202–E223PubMedCrossRef
7.
Zurück zum Zitat Park JY, Al-Hijji M, El Sabbagh A et al (2016) Acute coronary syndrome in active hematological malignancies: a cohort study of 5,300 patients. JACC 67(13 Supplement):585CrossRef Park JY, Al-Hijji M, El Sabbagh A et al (2016) Acute coronary syndrome in active hematological malignancies: a cohort study of 5,300 patients. JACC 67(13 Supplement):585CrossRef
8.
Zurück zum Zitat Navi BB, Reiner AS, Kamel H, Iadecola C, Okin PM, Elkind MSV, Panageas KS, DeAngelis LM (2017) Risk of arterial thromboembolism in patients with cancer. J Am Coll Cardiol 70(8):926–938PubMedPubMedCentralCrossRef Navi BB, Reiner AS, Kamel H, Iadecola C, Okin PM, Elkind MSV, Panageas KS, DeAngelis LM (2017) Risk of arterial thromboembolism in patients with cancer. J Am Coll Cardiol 70(8):926–938PubMedPubMedCentralCrossRef
9.
Zurück zum Zitat Lim SH, Wilson SM, Hunter A, Hill J, Beale P (2013) Takotsubo cardiomyopathy and 5-fluorouracil: getting to the heart of the matter. Case Rep Oncol Med 2013:206765PubMedPubMedCentral Lim SH, Wilson SM, Hunter A, Hill J, Beale P (2013) Takotsubo cardiomyopathy and 5-fluorouracil: getting to the heart of the matter. Case Rep Oncol Med 2013:206765PubMedPubMedCentral
10.
Zurück zum Zitat Rohrmann S, Witassek F, Erne P, Rickli H, Radovanovic D (2018) Treatment of patients with myocardial infarction depends on history of cancer. Eur Heart J Acute Cardiovasc Care 7(7):639–645PubMedCrossRef Rohrmann S, Witassek F, Erne P, Rickli H, Radovanovic D (2018) Treatment of patients with myocardial infarction depends on history of cancer. Eur Heart J Acute Cardiovasc Care 7(7):639–645PubMedCrossRef
11.
Zurück zum Zitat Velders MA, Boden H, Hofma SH, Osanto S, van der Hoeven BL, Heestermans AACM, Cannegieter SC, Jukema JW, Umans VAWM, Schalij MJ, van Boven AJ (2013) Outcome after ST elevation myocardial infarction in patients with cancer treated with primary percutaneous coronary intervention. Am J Cardiol 112(12):1867–1872PubMedCrossRef Velders MA, Boden H, Hofma SH, Osanto S, van der Hoeven BL, Heestermans AACM, Cannegieter SC, Jukema JW, Umans VAWM, Schalij MJ, van Boven AJ (2013) Outcome after ST elevation myocardial infarction in patients with cancer treated with primary percutaneous coronary intervention. Am J Cardiol 112(12):1867–1872PubMedCrossRef
12.
Zurück zum Zitat Sulpher J, Dattilo F, Dent S, Turek M, Reaume MN, Johnson C. Acute cardiogenic shock induced by infusional 5-fluorouracil. Case Rep Oncol Med 2014;2014:819396CrossRef Sulpher J, Dattilo F, Dent S, Turek M, Reaume MN, Johnson C. Acute cardiogenic shock induced by infusional 5-fluorouracil. Case Rep Oncol Med 2014;2014:819396CrossRef
13.
Zurück zum Zitat Zamorano JL, Lancellotti P, Rodriguez Munoz D, et al. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC). Eur Heart J 2016;37(36):2768–2801PubMedCrossRef Zamorano JL, Lancellotti P, Rodriguez Munoz D, et al. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC). Eur Heart J 2016;37(36):2768–2801PubMedCrossRef
14.
Zurück zum Zitat Manual of cardio-oncology. Cardiovascular care in the cancer patient. 2017 ed: Springer International Publishing Switzerland 2017; 2017 Manual of cardio-oncology. Cardiovascular care in the cancer patient. 2017 ed: Springer International Publishing Switzerland 2017; 2017
15.
Zurück zum Zitat Ozaki T, Chiba S, Annen K, Kawamukai Y, Kohno N, Horimoto M (2010) Acute coronary syndrome due to coronary artery compression by a metastatic cardiac tumor. J Cardiol Cases 1(1):e52–ee5PubMedCrossRef Ozaki T, Chiba S, Annen K, Kawamukai Y, Kohno N, Horimoto M (2010) Acute coronary syndrome due to coronary artery compression by a metastatic cardiac tumor. J Cardiol Cases 1(1):e52–ee5PubMedCrossRef
16.
Zurück zum Zitat Nogales-Romo MT, Tirado G, Freitas-Ferraz A, Martínez-Losas P, Rodrigo JL, Alswies A, Saiz-Pardo M, Ruiz-Mateos B, Viana-Tejedor A, Fernández-Ortiz A, Macaya C, Núñez-Gil IJ (2016) Coronary embolism of left atrial myxoma coexisting with severe aortic stenosis and atherosclerotic coronary disease. Int J Cardiol 203:315–316PubMedCrossRef Nogales-Romo MT, Tirado G, Freitas-Ferraz A, Martínez-Losas P, Rodrigo JL, Alswies A, Saiz-Pardo M, Ruiz-Mateos B, Viana-Tejedor A, Fernández-Ortiz A, Macaya C, Núñez-Gil IJ (2016) Coronary embolism of left atrial myxoma coexisting with severe aortic stenosis and atherosclerotic coronary disease. Int J Cardiol 203:315–316PubMedCrossRef
17.
Zurück zum Zitat Noguchi M, Yamada Y, Sakakura K, Katayama T, Momomura S, Ako J (2016) Coronary thrombus aspiration revealed tumorous embolism of myxofibrosarcoma from the left atrium. Cardiovasc Interv Ther 31(1):75–78PubMedCrossRef Noguchi M, Yamada Y, Sakakura K, Katayama T, Momomura S, Ako J (2016) Coronary thrombus aspiration revealed tumorous embolism of myxofibrosarcoma from the left atrium. Cardiovasc Interv Ther 31(1):75–78PubMedCrossRef
18.
Zurück zum Zitat Antonopoulos AS, Chrysohoou C, Lymperiadis D, Brili S, Tousoulis D (2016) Peripheral and coronary artery embolisms due to left ventricle fibroelastoma. Hell J Cardiol 57(5):368–370CrossRef Antonopoulos AS, Chrysohoou C, Lymperiadis D, Brili S, Tousoulis D (2016) Peripheral and coronary artery embolisms due to left ventricle fibroelastoma. Hell J Cardiol 57(5):368–370CrossRef
19.
Zurück zum Zitat Aronson D, Brenner B (2018) Arterial thrombosis and cancer. Thromb Res 164(Suppl 1):S23–Ss8PubMedCrossRef Aronson D, Brenner B (2018) Arterial thrombosis and cancer. Thromb Res 164(Suppl 1):S23–Ss8PubMedCrossRef
20.
Zurück zum Zitat Farmakis D, Mantzourani M, Filippatos G (2018) Anthracycline-induced cardiomyopathy: secrets and lies. Eur J Heart Fail 20(5):907–909PubMedCrossRef Farmakis D, Mantzourani M, Filippatos G (2018) Anthracycline-induced cardiomyopathy: secrets and lies. Eur J Heart Fail 20(5):907–909PubMedCrossRef
21.
Zurück zum Zitat Cardinale D, Colombo A, Bacchiani G, Tedeschi I, Meroni CA, Veglia F, Civelli M, Lamantia G, Colombo N, Curigliano G, Fiorentini C, Cipolla CM (2015) Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy. Circulation. 131(22):1981–1988PubMedCrossRef Cardinale D, Colombo A, Bacchiani G, Tedeschi I, Meroni CA, Veglia F, Civelli M, Lamantia G, Colombo N, Curigliano G, Fiorentini C, Cipolla CM (2015) Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy. Circulation. 131(22):1981–1988PubMedCrossRef
22.
Zurück zum Zitat Ghadri JR, Wittstein IS, Prasad A, Sharkey S, Dote K, Akashi YJ, Cammann VL, Crea F, Galiuto L, Desmet W, Yoshida T, Manfredini R, Eitel I, Kosuge M, Nef HM, Deshmukh A, Lerman A, Bossone E, Citro R, Ueyama T, Corrado D, Kurisu S, Ruschitzka F, Winchester D, Lyon AR, Omerovic E, Bax JJ, Meimoun P, Tarantini G, Rihal C, Y.-Hassan S, Migliore F, Horowitz JD, Shimokawa H, Lüscher TF, Templin C International expert consensus document on Takotsubo syndrome (part I): clinical characteristics, diagnostic criteria, and pathophysiology. Eur Heart J 2018;39(22):2032–2046PubMedPubMedCentralCrossRef Ghadri JR, Wittstein IS, Prasad A, Sharkey S, Dote K, Akashi YJ, Cammann VL, Crea F, Galiuto L, Desmet W, Yoshida T, Manfredini R, Eitel I, Kosuge M, Nef HM, Deshmukh A, Lerman A, Bossone E, Citro R, Ueyama T, Corrado D, Kurisu S, Ruschitzka F, Winchester D, Lyon AR, Omerovic E, Bax JJ, Meimoun P, Tarantini G, Rihal C, Y.-Hassan S, Migliore F, Horowitz JD, Shimokawa H, Lüscher TF, Templin C International expert consensus document on Takotsubo syndrome (part I): clinical characteristics, diagnostic criteria, and pathophysiology. Eur Heart J 2018;39(22):2032–2046PubMedPubMedCentralCrossRef
23.
Zurück zum Zitat Giza DE, Lopez-Mattei J, Vejpongsa P et al (2017) Stress-induced cardiomyopathy in cancer patients. Am J Cardiol 120(12):2284–2288PubMedCrossRef Giza DE, Lopez-Mattei J, Vejpongsa P et al (2017) Stress-induced cardiomyopathy in cancer patients. Am J Cardiol 120(12):2284–2288PubMedCrossRef
24.
Zurück zum Zitat Munoz E, Iliescu G, Vejpongsa P, Charitakis K, Karimzad K, Lopez-Mattei J, Yusuf SW, Marmagkiolis K, Iliescu C (2016) Takotsubo stress cardiomyopathy: “good news” in cancer patients? J Am Coll Cardiol 68(10):1143–1144PubMedCrossRef Munoz E, Iliescu G, Vejpongsa P, Charitakis K, Karimzad K, Lopez-Mattei J, Yusuf SW, Marmagkiolis K, Iliescu C (2016) Takotsubo stress cardiomyopathy: “good news” in cancer patients? J Am Coll Cardiol 68(10):1143–1144PubMedCrossRef
25.
Zurück zum Zitat Fernandez SF BM, Canty JM Jr. Takotsubo cardiomyopathy following initial chemotherapy presenting with syncope and cardiogenic shock – a case report and literature review. J Clin Exp Cardiol 2:124 2011 Fernandez SF BM, Canty JM Jr. Takotsubo cardiomyopathy following initial chemotherapy presenting with syncope and cardiogenic shock – a case report and literature review. J Clin Exp Cardiol 2:124 2011
26.
Zurück zum Zitat Burgdorf C, Kurowski V, Bonnemeier H, Schunkert H, Radke PW (2008) Long-term prognosis of the transient left ventricular dysfunction syndrome (Tako-Tsubo cardiomyopathy): focus on malignancies. Eur J Heart Fail 10(10):1015–1019PubMedCrossRef Burgdorf C, Kurowski V, Bonnemeier H, Schunkert H, Radke PW (2008) Long-term prognosis of the transient left ventricular dysfunction syndrome (Tako-Tsubo cardiomyopathy): focus on malignancies. Eur J Heart Fail 10(10):1015–1019PubMedCrossRef
27.
Zurück zum Zitat Madias JE (2016) What is/are the trigger(s) of takotsubo syndrome in cancer patients receiving chemotherapy? Int J Cardiol 222:253PubMedCrossRef Madias JE (2016) What is/are the trigger(s) of takotsubo syndrome in cancer patients receiving chemotherapy? Int J Cardiol 222:253PubMedCrossRef
28.
Zurück zum Zitat Franco TH, Khan A, Joshi V, Thomas B (2008) Takotsubo cardiomyopathy in two men receiving bevacizumab for metastatic cancer. Ther Clin Risk Manag 4(6):1367–1370PubMedPubMedCentralCrossRef Franco TH, Khan A, Joshi V, Thomas B (2008) Takotsubo cardiomyopathy in two men receiving bevacizumab for metastatic cancer. Ther Clin Risk Manag 4(6):1367–1370PubMedPubMedCentralCrossRef
29.
Zurück zum Zitat Santos JRU, Brofferio A, Viana B, Pacak K (2018) Catecholamine-induced cardiomyopathy in pheochromocytoma: how to manage a rare complication in a rare disease? Horm Metab Res Santos JRU, Brofferio A, Viana B, Pacak K (2018) Catecholamine-induced cardiomyopathy in pheochromocytoma: how to manage a rare complication in a rare disease? Horm Metab Res
30.
31.
Zurück zum Zitat Assefa D, Welsch J, Laubner K, Burgdorf C, Kotzerke M (2015) Cardiogenic shock due to atypical Tako-Tsubo cardiomyopathy in a young woman with pheochromocytoma. Deutsche medizinische Wochenschrift (1946). 140(6):422–425CrossRef Assefa D, Welsch J, Laubner K, Burgdorf C, Kotzerke M (2015) Cardiogenic shock due to atypical Tako-Tsubo cardiomyopathy in a young woman with pheochromocytoma. Deutsche medizinische Wochenschrift (1946). 140(6):422–425CrossRef
32.
Zurück zum Zitat Chiang YL, Chen PC, Lee CC, Chua SK (2016) Adrenal pheochromocytoma presenting with Takotsubo-pattern cardiomyopathy and acute heart failure: a case report and literature review. Medicine. 95(36):e4846PubMedPubMedCentralCrossRef Chiang YL, Chen PC, Lee CC, Chua SK (2016) Adrenal pheochromocytoma presenting with Takotsubo-pattern cardiomyopathy and acute heart failure: a case report and literature review. Medicine. 95(36):e4846PubMedPubMedCentralCrossRef
33.
Zurück zum Zitat Di Palma G, Daniele GP, Antonini-Canterin F, Piazza R, Nicolosi GL (2010) Cardiogenic shock with basal transient left ventricular ballooning (Takotsubo-like cardiomyopathy) as first presentation of pheochromocytoma. J Cardiovasc Med (Hagerstown) 11(7):507–510CrossRef Di Palma G, Daniele GP, Antonini-Canterin F, Piazza R, Nicolosi GL (2010) Cardiogenic shock with basal transient left ventricular ballooning (Takotsubo-like cardiomyopathy) as first presentation of pheochromocytoma. J Cardiovasc Med (Hagerstown) 11(7):507–510CrossRef
34.
Zurück zum Zitat Law C, Khaliq A, Guglin M (2013) Reversible cardiogenic shock due to catecholamine-induced cardiomyopathy: a variant of takotsubo? Am J Emerg Med 31(11):1621.e1–1621.e3CrossRef Law C, Khaliq A, Guglin M (2013) Reversible cardiogenic shock due to catecholamine-induced cardiomyopathy: a variant of takotsubo? Am J Emerg Med 31(11):1621.e1–1621.e3CrossRef
35.
Zurück zum Zitat Hekimian G, Kharcha F, Brechot N et al (2016) Extracorporeal membrane oxygenation for pheochromocytoma-induced cardiogenic shock. Ann Intensive Care 6(1):117PubMedPubMedCentralCrossRef Hekimian G, Kharcha F, Brechot N et al (2016) Extracorporeal membrane oxygenation for pheochromocytoma-induced cardiogenic shock. Ann Intensive Care 6(1):117PubMedPubMedCentralCrossRef
36.
Zurück zum Zitat Flam B, Broome M, Frenckner B, Branstrom R, Bell M (2015) Pheochromocytoma-induced inverted takotsubo-like cardiomyopathy leading to cardiogenic shock successfully treated with extracorporeal membrane oxygenation. J Intensive Care Med 30(6):365–372PubMedCrossRef Flam B, Broome M, Frenckner B, Branstrom R, Bell M (2015) Pheochromocytoma-induced inverted takotsubo-like cardiomyopathy leading to cardiogenic shock successfully treated with extracorporeal membrane oxygenation. J Intensive Care Med 30(6):365–372PubMedCrossRef
37.
Zurück zum Zitat Tsibiribi P, Bui-Xuan C, Bui-Xuan B, Lombard-Bohas C, Duperret S, Belkhiria M, Tabib A, Maujean G, Descotes J, Timour Q (2006) Cardiac lesions induced by 5-fluorouracil in the rabbit. Hum Exp Toxicol 25(6):305–309PubMedCrossRef Tsibiribi P, Bui-Xuan C, Bui-Xuan B, Lombard-Bohas C, Duperret S, Belkhiria M, Tabib A, Maujean G, Descotes J, Timour Q (2006) Cardiac lesions induced by 5-fluorouracil in the rabbit. Hum Exp Toxicol 25(6):305–309PubMedCrossRef
38.
Zurück zum Zitat Sasson Z, Morgan CD, Wang B, Thomas G, MacKenzie B, Platts ME (1994) 5-Fluorouracil related toxic myocarditis: case reports and pathological confirmation. Can J Cardiol 10(8):861–864PubMed Sasson Z, Morgan CD, Wang B, Thomas G, MacKenzie B, Platts ME (1994) 5-Fluorouracil related toxic myocarditis: case reports and pathological confirmation. Can J Cardiol 10(8):861–864PubMed
39.
Zurück zum Zitat Sellier-Leclerc AL, Belli E, Guerin V, Dorfmuller P, Deschenes G (2013) Fulminant viral myocarditis after rituximab therapy in pediatric nephrotic syndrome. Pediatr Nephrol 28(9):1875–1879PubMedCrossRef Sellier-Leclerc AL, Belli E, Guerin V, Dorfmuller P, Deschenes G (2013) Fulminant viral myocarditis after rituximab therapy in pediatric nephrotic syndrome. Pediatr Nephrol 28(9):1875–1879PubMedCrossRef
40.
Zurück zum Zitat Alonso JJ, Canovas A, Rubio G (2013) Lethal enterovirus myocarditis associated with rituximab and chemotherapy for follicular lymphoma. Med Clin 141(10):459–460CrossRef Alonso JJ, Canovas A, Rubio G (2013) Lethal enterovirus myocarditis associated with rituximab and chemotherapy for follicular lymphoma. Med Clin 141(10):459–460CrossRef
41.
Zurück zum Zitat Asnani A (2018) Cardiotoxicity of immunotherapy: incidence, diagnosis, and management. Curr Oncol Rep 20(6):44PubMedCrossRef Asnani A (2018) Cardiotoxicity of immunotherapy: incidence, diagnosis, and management. Curr Oncol Rep 20(6):44PubMedCrossRef
42.
Zurück zum Zitat Johnson DB, Balko JM, Compton ML et al (2016) Fulminant myocarditis with combination immune checkpoint blockade. N Eng J Med 375(18):1749–1755CrossRef Johnson DB, Balko JM, Compton ML et al (2016) Fulminant myocarditis with combination immune checkpoint blockade. N Eng J Med 375(18):1749–1755CrossRef
43.
Zurück zum Zitat Sauer R, Kiewe P, Desole M et al (2017) Lymphocytic myocarditis in a patient with metastatic clear cell renal cell carcinoma treated with nivolumab. Pathologe 38(6):535–539PubMedCrossRef Sauer R, Kiewe P, Desole M et al (2017) Lymphocytic myocarditis in a patient with metastatic clear cell renal cell carcinoma treated with nivolumab. Pathologe 38(6):535–539PubMedCrossRef
44.
Zurück zum Zitat Cheung CC, Constantine M, Ahmadi A, Shiau C, Chen LYC (2017) Eosinophilic myocarditis. Am J Med Sci 354(5):486–492PubMedCrossRef Cheung CC, Constantine M, Ahmadi A, Shiau C, Chen LYC (2017) Eosinophilic myocarditis. Am J Med Sci 354(5):486–492PubMedCrossRef
45.
Zurück zum Zitat Biedka M, Ziolkowska E, Windorbska W (2012) Acute pulmonary embolus in the course of cancer. Contemp Oncol 16(5):388–393 Biedka M, Ziolkowska E, Windorbska W (2012) Acute pulmonary embolus in the course of cancer. Contemp Oncol 16(5):388–393
46.
Zurück zum Zitat Silva P, Rosales M, Milheiro MJ, Santos LL (2015) Pulmonary embolism in ambulatory oncologic patients. Acta Med Port 28(4):463–468PubMedCrossRef Silva P, Rosales M, Milheiro MJ, Santos LL (2015) Pulmonary embolism in ambulatory oncologic patients. Acta Med Port 28(4):463–468PubMedCrossRef
47.
Zurück zum Zitat Bach AG, Neumann J, Taute BM, Surov A (2016) Frequency, cause, and awareness of pulmonary embolism in oncologic patients. Dtsch Med Wochenschr 141(10):713–717PubMedCrossRef Bach AG, Neumann J, Taute BM, Surov A (2016) Frequency, cause, and awareness of pulmonary embolism in oncologic patients. Dtsch Med Wochenschr 141(10):713–717PubMedCrossRef
48.
Zurück zum Zitat Jones DH, Schlatter MG, Cornelius AS, Neirotti RA (2000) A massive pulmonary tumor embolism after surgical manipulation and biopsy of a pelvic mass. Anesth Analg 90(2):322–323PubMed Jones DH, Schlatter MG, Cornelius AS, Neirotti RA (2000) A massive pulmonary tumor embolism after surgical manipulation and biopsy of a pelvic mass. Anesth Analg 90(2):322–323PubMed
49.
Zurück zum Zitat Choi EJ, Jin GY (2017) Pulmonary embolism after percutaneous cryoablation for lung cancer: a case report. J Vasc Interv Radiol 28(9):1285–1287PubMedCrossRef Choi EJ, Jin GY (2017) Pulmonary embolism after percutaneous cryoablation for lung cancer: a case report. J Vasc Interv Radiol 28(9):1285–1287PubMedCrossRef
50.
Zurück zum Zitat Lin HF, Liao KF, Chang CM, Lin CL, Lai SW, Hsu CY (2018) Correlation of the tamoxifen use with the increased risk of deep vein thrombosis and pulmonary embolism in elderly women with breast cancer: a case-control study. Medicine. 97(51):e12842PubMedPubMedCentralCrossRef Lin HF, Liao KF, Chang CM, Lin CL, Lai SW, Hsu CY (2018) Correlation of the tamoxifen use with the increased risk of deep vein thrombosis and pulmonary embolism in elderly women with breast cancer: a case-control study. Medicine. 97(51):e12842PubMedPubMedCentralCrossRef
51.
Zurück zum Zitat Keefe D, Bowen J, Gibson R, Tan T, Okera M, Stringer A (2011) Noncardiac vascular toxicities of vascular endothelial growth factor inhibitors in advanced cancer: a review. Oncologist 16(4):432–444PubMedPubMedCentralCrossRef Keefe D, Bowen J, Gibson R, Tan T, Okera M, Stringer A (2011) Noncardiac vascular toxicities of vascular endothelial growth factor inhibitors in advanced cancer: a review. Oncologist 16(4):432–444PubMedPubMedCentralCrossRef
52.
Zurück zum Zitat Bois MC, Eckhardt MD, Cracolici VM et al (2018) Neoplastic embolization to systemic and pulmonary arteries. J Vasc Surg 68(1):204–212 e7PubMedCrossRef Bois MC, Eckhardt MD, Cracolici VM et al (2018) Neoplastic embolization to systemic and pulmonary arteries. J Vasc Surg 68(1):204–212 e7PubMedCrossRef
53.
Zurück zum Zitat von Herbay A, Illes A, Waldherr R, Otto HF (1990) Pulmonary tumor thrombotic microangiopathy with pulmonary hypertension. Cancer. 66(3):587–592CrossRef von Herbay A, Illes A, Waldherr R, Otto HF (1990) Pulmonary tumor thrombotic microangiopathy with pulmonary hypertension. Cancer. 66(3):587–592CrossRef
54.
Zurück zum Zitat Han S, Kreit J (2013) 1242: Cardiogenic shock from pulmonary tumor thrombotic microangiopathy. 41(12):A319 Han S, Kreit J (2013) 1242: Cardiogenic shock from pulmonary tumor thrombotic microangiopathy. 41(12):A319
55.
Zurück zum Zitat Ohguchi H, Imaeda K, Hotta A, Kakoi S, Yasuda S, Shimizu Y, Hayakawa A, Mishina H, Hasegawa C, Ito S, Ogawa K, Yagi T, Koyama H, Tanaka T, Kato H, Takahashi S, Joh T (2018) An autopsy case of pulmonary tumor thrombotic microangiopathy due to rapidly progressing colon cancer in a patient with type 2 diabetes. Intern Med 57(17):2533–2539PubMedPubMedCentralCrossRef Ohguchi H, Imaeda K, Hotta A, Kakoi S, Yasuda S, Shimizu Y, Hayakawa A, Mishina H, Hasegawa C, Ito S, Ogawa K, Yagi T, Koyama H, Tanaka T, Kato H, Takahashi S, Joh T (2018) An autopsy case of pulmonary tumor thrombotic microangiopathy due to rapidly progressing colon cancer in a patient with type 2 diabetes. Intern Med 57(17):2533–2539PubMedPubMedCentralCrossRef
56.
Zurück zum Zitat Vincent F, Lamblin N, Classe M, Schurtz G, Rauch A, Fertin M, de Groote P (2017) Subacute right heart failure revealing three simultaneous causes of post-embolic pulmonary hypertension in metastatic dissemination of breast cancer. ESC Heart Fail 4(1):75–77PubMedCrossRef Vincent F, Lamblin N, Classe M, Schurtz G, Rauch A, Fertin M, de Groote P (2017) Subacute right heart failure revealing three simultaneous causes of post-embolic pulmonary hypertension in metastatic dissemination of breast cancer. ESC Heart Fail 4(1):75–77PubMedCrossRef
58.
Zurück zum Zitat Okubo Y, Wakayama M, Kitahara K, Nemoto T, Yokose T, Abe F, Hiruta N, Sasai D, Shinozaki M, Nakayama H, Ishiwatari T, Shibuya K (2011) Pulmonary tumor thrombotic microangiopathy induced by gastric carcinoma: morphometric and immunohistochemical analysis of six autopsy cases. Diagn Pathol 6:27PubMedPubMedCentralCrossRef Okubo Y, Wakayama M, Kitahara K, Nemoto T, Yokose T, Abe F, Hiruta N, Sasai D, Shinozaki M, Nakayama H, Ishiwatari T, Shibuya K (2011) Pulmonary tumor thrombotic microangiopathy induced by gastric carcinoma: morphometric and immunohistochemical analysis of six autopsy cases. Diagn Pathol 6:27PubMedPubMedCentralCrossRef
59.
Zurück zum Zitat Tsujimoto N, Miyoshi A, Mimura M, Naka T, Yamasaki M, Yokoi T (2018) Case report: pulmonary tumor thrombotic microangiopathy in a cervical cancer patient. Gynecol Obstet Investig 83(1):99–104CrossRef Tsujimoto N, Miyoshi A, Mimura M, Naka T, Yamasaki M, Yokoi T (2018) Case report: pulmonary tumor thrombotic microangiopathy in a cervical cancer patient. Gynecol Obstet Investig 83(1):99–104CrossRef
60.
Zurück zum Zitat Purga SL, Narula N, Horn EM, Karas MG (2015) Pulmonary tumour thrombotic microangiopathy as a cause of new-onset pulmonary hypertension in a patient with metastatic low-grade serous ovarian cancer. BMJ Case Rep 2015 Purga SL, Narula N, Horn EM, Karas MG (2015) Pulmonary tumour thrombotic microangiopathy as a cause of new-onset pulmonary hypertension in a patient with metastatic low-grade serous ovarian cancer. BMJ Case Rep 2015
61.
Zurück zum Zitat Takayama T, Okura Y, Okada Y, Honma K, Nashimoto A, Sato N, Yokoyama A, Minamino T (2015) Characteristics of neoplastic cardiac tamponade and prognosis after pericardiocentesis: a single-center study of 113 consecutive cancer patients. Int J Clin Oncol 20(5):872–877PubMedCrossRef Takayama T, Okura Y, Okada Y, Honma K, Nashimoto A, Sato N, Yokoyama A, Minamino T (2015) Characteristics of neoplastic cardiac tamponade and prognosis after pericardiocentesis: a single-center study of 113 consecutive cancer patients. Int J Clin Oncol 20(5):872–877PubMedCrossRef
62.
Zurück zum Zitat Khan UA, Shanholtz CB, McCurdy MT (2017) Oncologic mechanical emergencies. Hematol Oncol Clin North Am 31(6):927–940PubMedCrossRef Khan UA, Shanholtz CB, McCurdy MT (2017) Oncologic mechanical emergencies. Hematol Oncol Clin North Am 31(6):927–940PubMedCrossRef
63.
Zurück zum Zitat Abdelnaby M, Almaghraby A, Saleh Y, Abayazeed R (2018) Pericardial sarcoma. BMJ Case Rep 2018 Abdelnaby M, Almaghraby A, Saleh Y, Abayazeed R (2018) Pericardial sarcoma. BMJ Case Rep 2018
64.
Zurück zum Zitat Chen YY, Huang WC, Huang MH, Lu TM, Hsu CP (2018) The intra-pericardial paraganglioma presenting as ascites and hemopericardium with impending tamponade. Int Heart J 59(3):664–667PubMedCrossRef Chen YY, Huang WC, Huang MH, Lu TM, Hsu CP (2018) The intra-pericardial paraganglioma presenting as ascites and hemopericardium with impending tamponade. Int Heart J 59(3):664–667PubMedCrossRef
65.
Zurück zum Zitat Nagarsheth NP, Harrison M, Kalir T, Rahaman J (2006) Malignant pericardial effusion with cardiac tamponade in a patient with metastatic vaginal adenocarcinoma. Int J Gynecol Cancer 16(3):1458–1461PubMedCrossRef Nagarsheth NP, Harrison M, Kalir T, Rahaman J (2006) Malignant pericardial effusion with cardiac tamponade in a patient with metastatic vaginal adenocarcinoma. Int J Gynecol Cancer 16(3):1458–1461PubMedCrossRef
66.
Zurück zum Zitat Oka Y, Okada K, Miyake Y, et al. [Three cases of gastric cancer with rare presentation of oncologic emergency]. Gan to kagaku ryoho Cancer & chemotherapy 2016;43(12):2398–2400 Oka Y, Okada K, Miyake Y, et al. [Three cases of gastric cancer with rare presentation of oncologic emergency]. Gan to kagaku ryoho Cancer & chemotherapy 2016;43(12):2398–2400
67.
Zurück zum Zitat Chen X, Miao Q, Yu Y et al Blunt trauma-induced pericardial tamponade after video-assisted thoracoscopic surgery. Ann Thorac Surg Chen X, Miao Q, Yu Y et al Blunt trauma-induced pericardial tamponade after video-assisted thoracoscopic surgery. Ann Thorac Surg
68.
Zurück zum Zitat Chung MW, Ha SY, Choi JH, Park HJ, Myung DS, Cho SB, Lee WS, Kim JW, Oh HH, Joo YE (2018) Cardiac tamponade after radiofrequency ablation for hepatocellular carcinoma: case report and literature review. Medicine. 97(49):e13532PubMedPubMedCentralCrossRef Chung MW, Ha SY, Choi JH, Park HJ, Myung DS, Cho SB, Lee WS, Kim JW, Oh HH, Joo YE (2018) Cardiac tamponade after radiofrequency ablation for hepatocellular carcinoma: case report and literature review. Medicine. 97(49):e13532PubMedPubMedCentralCrossRef
69.
Zurück zum Zitat Gonzalo Baron Esquivias RA (2015) Cardiac management of oncology patients. Springer Gonzalo Baron Esquivias RA (2015) Cardiac management of oncology patients. Springer
70.
Zurück zum Zitat Sundaram VR, Abbas T (2018) Cardiac tamponade induced by dabrafenib and trametinib combination therapy for melanoma: case report. Medicine. 97(44):e12751PubMedPubMedCentralCrossRef Sundaram VR, Abbas T (2018) Cardiac tamponade induced by dabrafenib and trametinib combination therapy for melanoma: case report. Medicine. 97(44):e12751PubMedPubMedCentralCrossRef
71.
Zurück zum Zitat Burkhart T, Keith MCL, Lenneman CAG, Fernando RR (2018) Bortezomib-induced cardiac tamponade in a 49-year-old man. Tex Heart Inst J 45(4):260–263PubMedPubMedCentralCrossRef Burkhart T, Keith MCL, Lenneman CAG, Fernando RR (2018) Bortezomib-induced cardiac tamponade in a 49-year-old man. Tex Heart Inst J 45(4):260–263PubMedPubMedCentralCrossRef
72.
Zurück zum Zitat Asai M, Kato Y, Kawai S, et al. Management of cardiac tamponade during nivolumab of lung cancer with intrapericardial bleomycin: case report2019 Asai M, Kato Y, Kawai S, et al. Management of cardiac tamponade during nivolumab of lung cancer with intrapericardial bleomycin: case report2019
73.
Zurück zum Zitat Zhao Y, Liu S (2017) Acute cardiac herniation after left Intrapericardial pneumonectomy. J Cardiothorac Vasc Anesth 31(1):270–273PubMedCrossRef Zhao Y, Liu S (2017) Acute cardiac herniation after left Intrapericardial pneumonectomy. J Cardiothorac Vasc Anesth 31(1):270–273PubMedCrossRef
74.
Zurück zum Zitat Alimi F, Marzouk M, Mgarrech I, Chemchik H, Limayem F (2016) Cardiac herniation after left intrapericardial pneumonectomy. Asian Cardiovasc Thorac Ann 24(6):590–592PubMedCrossRef Alimi F, Marzouk M, Mgarrech I, Chemchik H, Limayem F (2016) Cardiac herniation after left intrapericardial pneumonectomy. Asian Cardiovasc Thorac Ann 24(6):590–592PubMedCrossRef
75.
Zurück zum Zitat Zandberg FT, Verbeke SJ, Snijder RJ, Dalinghaus WH, Roeffel SM, Van Swieten HA (2004) Sudden cardiac herniation 6 months after right pneumonectomy. Ann Thorac Surg 78(3):1095–1097PubMedCrossRef Zandberg FT, Verbeke SJ, Snijder RJ, Dalinghaus WH, Roeffel SM, Van Swieten HA (2004) Sudden cardiac herniation 6 months after right pneumonectomy. Ann Thorac Surg 78(3):1095–1097PubMedCrossRef
76.
Zurück zum Zitat Norwood TG, Westbrook BC, Johnson DB, Litovsky SH, Terry NL, McKee SB, Gertler AS, Moslehi JJ, Conry RM (2017) Smoldering myocarditis following immune checkpoint blockade. J Immunother Cancer 5(1):91PubMedPubMedCentralCrossRef Norwood TG, Westbrook BC, Johnson DB, Litovsky SH, Terry NL, McKee SB, Gertler AS, Moslehi JJ, Conry RM (2017) Smoldering myocarditis following immune checkpoint blockade. J Immunother Cancer 5(1):91PubMedPubMedCentralCrossRef
77.
Zurück zum Zitat Keenan NG, Nicholson AG, Oldershaw PJ (2008) Fatal acute pulmonary hypertension caused by pulmonary tumour thrombotic microangiopathy. Int J Cardiol 124(1):e11–e13PubMedCrossRef Keenan NG, Nicholson AG, Oldershaw PJ (2008) Fatal acute pulmonary hypertension caused by pulmonary tumour thrombotic microangiopathy. Int J Cardiol 124(1):e11–e13PubMedCrossRef
78.
Zurück zum Zitat Miyazaki S, Ikeda T, Ito G, Inoue M, Nara K, Nishinaga Y, Hasegawa Y (2017) Pulmonary tumor thrombotic microangiopathy successfully treated with corticosteroids: a case report. J Med Case Rep 11(1):356PubMedPubMedCentralCrossRef Miyazaki S, Ikeda T, Ito G, Inoue M, Nara K, Nishinaga Y, Hasegawa Y (2017) Pulmonary tumor thrombotic microangiopathy successfully treated with corticosteroids: a case report. J Med Case Rep 11(1):356PubMedPubMedCentralCrossRef
79.
Zurück zum Zitat Ogawa A, Yamadori I, Matsubara O, Matsubara H (2013) Pulmonary tumor thrombotic microangiopathy with circulatory failure treated with imatinib. Intern Med 52(17):1927–1930PubMedCrossRef Ogawa A, Yamadori I, Matsubara O, Matsubara H (2013) Pulmonary tumor thrombotic microangiopathy with circulatory failure treated with imatinib. Intern Med 52(17):1927–1930PubMedCrossRef
80.
Zurück zum Zitat Higo K, Kubota K, Takeda A, Higashi M, Ohishi M (2014) Successful antemortem diagnosis and treatment of pulmonary tumor thrombotic microangiopathy. Intern Med 53(22):2595–2599PubMedCrossRef Higo K, Kubota K, Takeda A, Higashi M, Ohishi M (2014) Successful antemortem diagnosis and treatment of pulmonary tumor thrombotic microangiopathy. Intern Med 53(22):2595–2599PubMedCrossRef
81.
82.
83.
Zurück zum Zitat Farmakis D, Keramida K, Filippatos G (2018) How to build a cardio-oncology service? Eur J Heart Fail 20(12):1732–1734PubMedCrossRef Farmakis D, Keramida K, Filippatos G (2018) How to build a cardio-oncology service? Eur J Heart Fail 20(12):1732–1734PubMedCrossRef
Metadaten
Titel
Cardiogenic shock in cancer
verfasst von
Kalliopi Keramida
John T. Parissis
Ovidiu Chioncel
Dimitrios Farmakis
Publikationsdatum
04.07.2019
Verlag
Springer US
Erschienen in
Heart Failure Reviews / Ausgabe 6/2019
Print ISSN: 1382-4147
Elektronische ISSN: 1573-7322
DOI
https://doi.org/10.1007/s10741-019-09819-9

Weitere Artikel der Ausgabe 6/2019

Heart Failure Reviews 6/2019 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.